Literature DB >> 24367828

Acute coronary syndrome of paradoxical origin.

Ana Rita Ferreira, António Freitas, Pedro Magno, Ana Oliveira Soares, Pedro Farto e Abreu, José Pedro Neves, Victor M Gil.   

Abstract

We describe a rare case of acute myocardial infarction secondary to paradoxical embolism complicating acute pulmonary embolism. A 44-year-old woman presented to the emergency department with chest pain. The physical examination was unremarkable except for oxygen saturation of 75%, and the electrocardiogram showed ST-segment elevation in the inferior leads. Urgent coronary angiography showed a distal occlusion of the right coronary artery and multiple thrombi were aspirated. Despite relief of chest pain and electrocardiogram normalization, her oxygen saturation remained low (90%) with high-flow oxygen by mask. The transthoracic echocardiogram showed a mass in the left atrium and dilatation of the right chambers, while the transesophageal echocardiogram showed a thrombus attached to the interatrial septum in the region of the foramen ovale. Color flow imaging was consistent with a patent foramen ovale. Thoracic computed tomography angiography documented thrombi in both branches of the pulmonary trunk. After five days on anticoagulation, the patient underwent surgical foramen ovale closure.

Entities:  

Mesh:

Year:  2013        PMID: 24367828     DOI: 10.1016/j.repc.2013.09.002

Source DB:  PubMed          Journal:  Rev Port Cardiol        ISSN: 0870-2551            Impact factor:   1.374


  2 in total

1.  Failed primary percutaneous coronary intervention in a middle-aged man without cardiovascular risk factors: left atrium myxoma.

Authors:  Nahid Azdaki; Seyedali Moezi; Mahmood Hosseinzadehmaleki; Marjan Farzad
Journal:  Pan Afr Med J       Date:  2020-05-06

Review 2.  Nonatherosclerotic causes of acute coronary syndrome: recognition and management.

Authors:  Teresa Bastante; Fernando Rivero; Javier Cuesta; Amparo Benedicto; Jorge Restrepo; Fernando Alfonso
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.